Alpine Global Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Alpine Global Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 21, 2023	SELL	$98.98 - $115.74 $14 Million - $16.4 Million	-141,476 Reduced 61.26%	89,450 $10.3 Million
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $14 Million - $16.4 Million	-141,476 Reduced 61.26%	89,450 $10.3 Million
Q2 2023 Nov 21, 2023	BUY	$96.34 - $112.38 $15.5 Million - $18.1 Million	160,926 Added 229.89%	230,926 $23.8 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $15.5 Million - $18.1 Million	160,926 Added 229.89%	230,926 $23.8 Million
Q1 2023 Nov 21, 2023	SELL	$107.32 - $113.5 $2.09 Million - $2.21 Million	-19,450 Reduced 21.74%	70,000 $7.64 Million

Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $5.37 Million - $5.68 Million	50,000 Added 250.0%	70,000 $7.64 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $1.25 Million - $2.28 Million	20,000 New	20,000 $2.28 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $460,933 - $612,695	-6,417 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $429,939 - $541,530	6,417 New	6,417 $469,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.